These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9915227)

  • 21. MTHFR C677T, A1298C and ACE I/D polymorphisms as risk factors for diabetic nephropathy among type 2 diabetic patients.
    El-Baz R; Settin A; Ismaeel A; Khaleel AA; Abbas T; Tolba W; Abd Allah W; Sobh MA
    J Renin Angiotensin Aldosterone Syst; 2012 Dec; 13(4):472-7. PubMed ID: 22554825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary excretion of beta-thromboglobulin and N-acetyl-beta-D-glucosaminidase in type 1 diabetes: potential indicators of early nephropathy?
    Patrick AW; Oliver MD; Howie AF; Dawes J; Macintyre CC; Frier BM
    Diabete Metab; 1990; 16(5):441-7. PubMed ID: 2150050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microalbuminuria in non-insulin-dependent diabetes.
    Mogensen CE; Damsgaard EM; Frøland A; Nielsen S; de Fine Olivarius N; Schmitz A
    Clin Nephrol; 1992; 38 Suppl 1():S28-39. PubMed ID: 1295705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomere length and progression of diabetic nephropathy in patients with type 1 diabetes.
    Fyhrquist F; Tiitu A; Saijonmaa O; Forsblom C; Groop PH;
    J Intern Med; 2010 Mar; 267(3):278-86. PubMed ID: 19563389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Microalbuminuria in insulin-dependent diabetics: the prevention of diabetic nephropathy].
    Durruty P; Krause P; Pérez F; García de los Ríos M; López G; Durruty G
    Rev Med Chil; 1990 Dec; 118(12):1319-25. PubMed ID: 2152662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Type 2 diabetic nephropathy: clinical course and prevention proposals 2004].
    Tarchini R; Bottini E; Botti P; Marseglia CD; Talassi E; Baraldi O; Lambertini D; Gaetti L; Bellomi A
    G Ital Nefrol; 2005; 22 Suppl 31():S15-9. PubMed ID: 15786392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetic nephropathy in children and adolescents and its consequences in adults.
    Koulouridis E
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1367-77. PubMed ID: 11964036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetic nephropathy: diagnosis, prevention, and treatment.
    Gross JL; de Azevedo MJ; Silveiro SP; Canani LH; Caramori ML; Zelmanovitz T
    Diabetes Care; 2005 Jan; 28(1):164-76. PubMed ID: 15616252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening of diabetic patients for microalbuminuria in primary care--The PROSIT-Project. Proteinuria Screening and Intervention.
    Piehlmeier W; Renner R; Schramm W; Kimmerling T; Garbe S; Proetzsch R; Fahn J; Piwernetz K; Landgraf R
    Exp Clin Endocrinol Diabetes; 1999; 107(4):244-51. PubMed ID: 10433063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [What is new in the treatment of diabetes?--The importance of nephro- and cardioprotective management].
    Czekalski S
    Pol Arch Med Wewn; 2004 Oct; 112 Spec No():65-9. PubMed ID: 15669203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical usefulness of measurement of urinary albumin excretion in diabetes mellitus.
    Stehouwer CD; Donker AJ
    Neth J Med; 1993 Jun; 42(5-6):175-86. PubMed ID: 8377876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lower levels of HDL2 cholesterol are associated with microalbuminuria in patients with type 1 diabetes].
    Bulum T; Duvnjak L; Prkacin I
    Acta Med Croatica; 2011; 65(3):243-50. PubMed ID: 22359892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of genetic factors (HLA class II genes, insulin-gene region polymorphisms) and metabolic control on the development of diabetic nephropathy.
    Rønningen KS; Bangstad HJ; Undlien DE; Thorsby E
    Diabetes Res; 1993; 23(1):31-40. PubMed ID: 7924146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The link between microalbuminuria, endothelial dysfunction and cardiovascular disease in diabetes.
    Naidoo DP
    Cardiovasc J S Afr; 2002; 13(4):194-9. PubMed ID: 12389063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting the development of diabetic nephropathy and its progression.
    William J; Hogan D; Batlle D
    Adv Chronic Kidney Dis; 2005 Apr; 12(2):202-11. PubMed ID: 15822056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and therapeutic aspects of diabetic nephropathy.
    Strippoli GF; Di Paolo S; Cincione R; Di Palma AM; Teutonico A; Grandaliano G; Schena FP; Gesualdo L
    J Nephrol; 2003; 16(4):487-99. PubMed ID: 14696750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors.
    Ficociello LH; Perkins BA; Silva KH; Finkelstein DM; Ignatowska-Switalska H; Gaciong Z; Cupples LA; Aschengrau A; Warram JH; Krolewski AS
    Clin J Am Soc Nephrol; 2007 May; 2(3):461-9. PubMed ID: 17699452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preventing microalbuminuria in patients with type 2 diabetes.
    Jermendy G; Ruggenenti P
    Diabetes Metab Res Rev; 2007 Feb; 23(2):100-10. PubMed ID: 17094161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coeliac disease, gluten-free diet and the development and progression of albuminuria in children with type 1 diabetes.
    Gopee E; van den Oever EL; Cameron F; Thomas MC
    Pediatr Diabetes; 2013 Sep; 14(6):455-8. PubMed ID: 23763501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.